Parameter | Value |
---|---|
Patients | 13 |
Age (y, IQR) | 50.0 (34.5–53.5) |
Female, n (%) | 4 (31) |
BMI (kg/m2, IQR) | 31.0 (26.9-40.3) |
Survivors, n (%) | 10 (77) |
SOFA Score (IQR) | 10.0 (9.0-11.5) |
Acute renal failure, n (%) | 5 (38) |
Dialysis, n (%) | 1 (8) |
Creatinine (mg/dl, IQR) | 1.0 (0.6-3.4) |
Urea (mg/dl, IQR) | 91.0 (55.0-128.5) |
Mechanical ventilation, n (%) | 11 (85) |
Respiratory rate (/min, IQR) | 23.0 (14.5-26.5) |
pH (IQR) | 7.39 (7.35-7.44) |
paO2 (mmHg, IQR) | 70.0 (64.3-79.9) |
paCO2 (mmHg, IQR) | 45.6 (40.1-47.5) |
Antibiotics, n (%) | 8 (62) |
Transfusions (Red Blood Cells), n (%) | 2 (15) |
COVID-19, n (%) | 10 (77) |
VV ECMO, n (%) | 11 (85) |
- ARDS, n (%) | 11 (85) |
◦ COVID-19 associated, n (% of ARDS) | 9 (82) |
VA ECMO, n (%) | 2 (15) |
- Pulmonary Embolism, n (%) | 1 (8) |
- COVID-19 associated Perimyocarditis, n (%) | 1 (8) |
Type of ECMO, n (%) | |
- Stöckert Sorin | 7 (54) |
- Maquet | 3 (23) |
- Centrimag | 3 (23) |
Days on ECMO (d, IQR) | 1.0 (1.0-2.0) |
Blood flow (l/min, IQR) | 4.0 (3.1-4.8) |
FiO (%, IQR) in ECMO circuit | 100 (90-100) |
Noradrenalin, n (%) | 9 (69) |
Major bleeding, n (%) | 3 (23) |
- Intracerebral hemorrhage | 2 (15) |
Minor bleeding, n (%) | 4 (31) |
Heparin, n (%) | 10 (77) |
ASA, n (%) | 1 (8) |
Hemoglobin (g/dl, IQR) | 9.9 (9.2-10.5) |
Hematocrit (%, IQR) | 29.4 (27.5-30.7) |
Prothrombin time (s, IQR) | 11.4 (11.0-14.1) |
INR (IQR) | 1.1 (1.0-1.2) |
APTT (s, IQR) | 48.0 (31.5-61.0) |
Fibrinogen (mg/dl, IQR) | 386.0 (234.0-607.5) |
Platelets (x103/µl, IQR) | 225.0 (133.5-264.0) |
CRP (mg/l, IQR) | 62.9 (36.1-245.3) |
PCT (ng/ml, IQR) | 1.3 (0.2-3.6) |
Leukocytes (x 103/µl, IQR) | 11.2 (7.6-15.0) |
AST (U/l, IQR) | 105.0 (44.5-190.5) |
ALT (U/l, IQR) | 50.0 (35.0-133.5) |
Bilirubin (mg/dl, IQR) | 1.1 (0.5-1.4) |
Lactate (mmol/l, IQR) | 1.3 (0.9-1.8) |